EMA Panel Endorses Antibacterial Drug Trio Recarbrio EMA Panel Endorses Antibacterial Drug Trio Recarbrio

Recarbrio combines imipenem, cilastatin, and relebactam and is for the treatment of infections due to aerobic Gram-negative pathogens in adults with limited treatment options.International Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news